

Analysts initiated coverage on VYLR, IMTX, ENTG, SLGL and SPTX, assigning Neutral, Buy or Overweight ratings and price targets.
You can purchase shares of Sol-Gel Technologies (NASDAQ:SLGL) through any online brokerage.
Other companies in Sol-Gel Technologies’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Sol-Gel Technologies has a consensus price target of $145.00.
The stock price for Sol-Gel Technologies (NASDAQ: SLGL) is $64.165 last updated November 2, 2026 at 12:25 PM EST.
There are no upcoming dividends for Sol-Gel Technologies.
Sol-Gel Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for Sol-Gel Technologies.
Sol-Gel Technologies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610...